Advertisement

Latest News From "The Pink Sheet" DAILY - Lovenox Court Ruling Extends Hatch-Waxman "Safe Harbor"

02:18 EDT 7 Aug 2012 | BioPharma Today

Manufacturing patents in peril after Federal Circuit's Lovenox decision - Novartis and University of Pennsylvania to research chimeric antigen receptor immunotherapies - Eisai's cancer subsidiary H3 Biomedicine moves toward the clinic - FDA to hold s..

Original Article: Latest News From "The Pink Sheet" DAILY - Lovenox Court Ruling Extends Hatch-Waxman "Safe Harbor"

NEXT ARTICLE

More From BioPortfolio on "Latest News From "The Pink Sheet" DAILY - Lovenox Court Ruling Extends Hatch-Waxman "Safe Harbor""

Search BioPortfolio: